Home Company
Scientific Team Management Team Regulatory Process
Technologies and Products
Description of Technology New Method of 'Growing' Medicine Solutions for Arthritis Solutions for Cancer Nutraceuticals & Fitness
Arthritis
Forms of Arthritis Growing Health Problem Inflammation Current Treatment Market Osteoarthritis Our Solution to Arthritis
Cancer
Brief Background on Cancer Cancer Drugs Our Solution to Cancer
Investor Information
Revenue Model Investor Essentials Press Releases Stock Quote
Contact Us  

INVESTOR ESSENTIALS


Symbol: MTBR on the OTC:BB
SEC filings: For all of the company's SEC filings,
please visit the website of SEC at www.sec.gov.
Total number of issued
and outstanding shares
8,138,126 common shares
0 preferred shares
Year End: December 31st
Investor Relations
Princeton Research
Mike King
Tel. (702) 650-3000
email: mike@princetonresearch.com